Jiangsu Hengrui Medicine
600276.SS
#491
Rank
$40.59 B
Marketcap
$6.36
Share price
-0.52%
Change (1 day)
1.76%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Cash on Hand

Cash on Hand as of September 2023 : $2.45 B

According to Jiangsu Hengrui Medicine 's latest financial reports the company has $2.45 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Jiangsu Hengrui Medicine - Cash on Hand chart (from 2001 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31$2.59 B-11.8%
2021-12-31$2.93 B16.61%
2020-12-31$2.51 B29.76%
2019-12-31$1.94 B19.66%
2018-12-31$1.62 B147.39%
2017-12-31$0.65 B-7.28%
2016-12-31$0.70 B-10.68%
2015-12-31$0.79 B42.19%
2014-12-31$0.55 B55.4%
2013-12-31$0.35 B68.09%
2012-12-31$0.21 B41.16%
2011-12-31$0.15 B0.38%
2010-12-31$0.15 B45.33%
2009-12-31$0.10 B51.64%
2008-12-31$68.28 M-40.97%
2007-12-31$0.11 B56.61%
2006-12-31$73.85 M38.12%
2005-12-31$53.47 M21.61%
2004-12-31$43.96 M80.77%
2003-12-31$24.32 M5.2%
2002-12-31$23.12 M-29.38%
2001-12-31$32.73 M